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1. Introduction 
Because heart failure is a clinical syndrome that is caused by abnormal cardiac function, the 
major goals in the evaluation of patients with heart failure are: 1) to identify the nature and 
severity of the cardiac abnormality; 2) to characterize the nature and severity of the patient’s 
functional limitation; and 3) to assess the presence and severity of body fluid retention (Packer 
& Cohn, 1999). An accurate objective measurement of the presence of body fluid retention is 
necessary in order to evaluate whether or not heart failure status deteriorates. The difficulty 
in clinically defining such patients, however, stems from the fact that no simpler or more 
objective sign of body fluid accumulation is currently available because there is no clear cut-
off sign of fluid accumulation that can be used reliably to identify subjects with worsening 
or decompensated heart failure (Gheorghiade et al., 2010). In the recent years, technologies 
available for the assessment of body fluid status in heart failure patients are increasing in 
number, variety, and availability (Abraham et al., 2011; Blair et al., 2009; Kataoka, 2009a, 
2009b; McDonald, 2010; Tang & Tong, 2009). Chest ultrasound to evaluate pleural effusion 
or changes in lung status is an evolving imaging technique with novel uses in critically ill 
patients, including those with heart failure (Bouhemad et al., 2007; Evans & Gleeson, 2004; 
Havelock et al., 2010; Stefanidis et al., 2011). In uncontrolled heart failure, fluid accumulates 
throughout the body, including in the thorax. The accumulation and retention of body fluid 
in the pleural (Kataoka & Takada, 2000; Kataoka, 2007, 2010) and/or pericardial (Kataoka, 
2000; Movahed et al., 2006) cavities could be suitable targets for clinical evaluation by chest 
ultrasound in heart failure patients. This review article describes the application of this 
technique for the evaluation of pleural effusion in heart failure patients. 
2. Pathophysiology of heart failure-associated pleural effusion 
The pleural cavity contains a relatively small amount of fluid – approximately 10 ml on each 
side (Sahn, 1988). Pleural fluid volume is maintained by a balance between fluid production 
and removal, and changes in the rates of either can potentially result in the presence of 
excess fluid, traditionally known as pleural effusion (Miserocchi, 1997; Natanzon & 
Kronzon, 2009). Pathologic pleural effusion can be caused by a wide variety of intrathoracic 
and systemic diseases (Sahn, 1988). Pleural effusions are classified as either exudates, which 
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indicate a structural pleural abnormality, or transudates, which indicate an imbalance of the 
hydrostatic and oncotic pressures across the normal pleura (Agostoni et al., 1957; Paddock, 
1940). The main causes of structural pleural abnormalities include pulmonary infection, 
malignancy, pulmonary embolism, or collagen disease. Imbalanced pressure across the 
normal pleura, on the other hand, is due to heart failure, pulmonary atelectasis, 
hypoalbuminemia, hepatic hydrothorax, or nephritic syndrome (Azoulay, 2003; Golshan et 
al., 2002; Light et al., 1972; Mattison et al., 1997; Sahn, 1988). Decompensated heart failure 
with transudative pleural effusion is the most common cause of pleural effusion in many 
parts of the world. 
The syndrome of heart failure is the response of the body to the heart’s inability to maintain 
an adequate blood supply at a rate commensurate with the requirements of the 
metabolizing tissues. Arterial underfilling due to worsening of heart failure, either by 
diminished cardiac output or arterial vasodilatation, triggers activation of neurohormonal 
systems and derangement of renal function, that in turn incite heart failure-related body 
fluid retention (Ronco & Maisel, 2010; Schrier & Abraham, 1999; Sica, 2006), including 
pleural cavity. In decompensated heart failure, the accumulation of pleural effusion is more 
closely associated with left atrial pressure than right atrial pressure, suggesting that high-
pressure pulmonary edema due to left-sided heart failure, accumulating fluid in the lung 
passes through the visceral pleura and enters the pleural space (Wiener-Kronish et al., 1985, 
1987). In this condition, an elevated right atrial pressure might help to sustain or worsen 
pleural effusion by interfering with lymphatic drainage from the lung (Szabo & Magyar, 
1967). The volume of pleural effusion, however, is not known to be associated with 
pericardial effusion in decompensated heart failure patients (Kataoka, 2000). 
Early studies reported a right-sided predominance of heart-failure associated pleural 
effusion (Bedford & Lovibond, 1941; McPeak & Levine, 1946; White et al., 1947), but 
subsequent studies report mixed results regarding the lateralization of pleural effusion in 
heart failure, presumably due to differences in the assessment methods (Kataoka, 2000). A 
recent review article (Wong et al., 2009) systematically examined a large number of heart 
failure-associated pleural effusion studies and concluded: (1) most of the studies reported 
bilateral effusion, and (2) when asymmetry occurred, effusion was predominantly right-
sided (either unilateral or one side larger than the other) with summary prevalence for 
unilateral or larger right-sided effusion at 47% compared with left-sided prevalence of 19%. 
The findings of a previous study, in which heart failure-associated pleural effusion was 
quantitatively assessed using computed tomography, support the observations summarized 
above (Kataoka, 2000). In that study, as many as 52 (87%) of 60 acutely decompensated heart 
failure patients had pleural effusion. Of 52 heart failure patients with pleural effusion, 45 
(87%) had bilateral effusion, 5 (10%) had right-sided effusion only, and 2 (3%) had left-sided 
effusion only. Among the 45 patients with bilateral pleural effusion, 20 (44%) patients had 
predominantly right-sided effusion (interhemithoracic difference of the pleural volume > 
100 ml), 23 (51%) patients had equally bilateral effusion, and only 2 (5%) had predominantly 
left-sided effusion. 
Multiple explanations for the asymmetry in heart failure-associated pleural effusion have 
been proposed based on the results of several studies. Among these studies of the right-side 
preponderance of pleural effusion in heart failure patients, one study presented impressive 
evidence that the anatomic and hydrostatic factors relating to blood flow from the 
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pulmonary venous bed to the left ventricle strongly favored the predominance of pleural 
effusion in the right hemithorax (Dock, 1935). In addition, these factors are augmented by 
the generally preferred right lateral decubitus position of heart failure patients as revealed 
by studies on trepopnea (Wood, et al., 1937; de Araujo et al., 2011). An older study 
attributed the right side predominance of pleural effusion to the greater extent of lung and 
pleural surfaces on the right side relative to the left side (White et al., 1947). To date, 
however, none of the theories regarding the right-sided polarity of pleural effusion in 
patients with heart failure has been universally accepted (Natanzon & Kronzon, 2009). 
3. Sonographic evaluation of pleural effusion in heart failure 
The classical symptoms of heart failure are dyspnea, palpitation, and fatigue. Dyspnea on 
exertion is common in the general population, particularly in patients with respiratory 
disease or in the obese, and, therefore, it cannot be used as the selection criterion for the 
diagnosis of heart failure. Orthopnea and paroxysmal nocturnal dyspnea are less common 
in the general population than dyspnea alone, but less sensitive, for the diagnosis of heart 
failure (Ahmed et al., 2004; Fonseca et al., 2004; Mueller et al., 2005). 
Body fluid retention in worsening heart failure is reflected in physical signs of congestion, 
such as fluid body weight gain, leg edema, jugular venous distension and pulmonary 
crackles. As for pleural effusion, some studies suggest the possibility of physical 
examination maneuver to detect pleural effusion as little as 50 ml (Bernstein & White, 1952; 
Guarino & Guarino, 1994). However, none of these physical signs of fluid retention is 
particularly sensitive, though specificity varies among studies (Fonseca et al., 2004; Mueller 
et al., 2005; Rohde et al, 2004; Stevenson & Perloff, 1989; Tresch, 1997). These limited roles of 
heart failure-associated physical findings and poor prediction of symptoms for identifying 
worsening heart failure status emphasize the need for additional diagnostic tools. Chest 
ultrasound might be one of these diagnostic tools, but this modality is not yet in widespread 
use. Evaluation of the clinical utility of this method for assessing heart failure patients is 
therefore important. 
3.1 Chest ultrasound technique 
The patient is placed in a sitting position on a bed or chair, and chest ultrasound is 
performed on each hemithorax using a transducer through the intercostal space, and 
scanning is performed along the paravertebral, scapular, and posterior axillary lines 
(Kataoka & Takada, 2000; Kataoka, 2007; Piccoli et al., 2005; Waggoner et al., 1995). Using a 
high resolution (3.5-5.0 MHz) transducer applied to the chest wall, the parietal pleura lining 
the bony thorax and the visceral pleura covering the lung are seen just beneath the chest 
wall as two thin and bright echogenic lines. Normally, the two pleural lines are smooth and 
less than 2 mm thick (Mathis, 1997). These higher frequency transducers, while providing 
superior spatial resolution, may be limited by insufficient penetration (Warakaulle & Traill, 
2004) and thus inadequate for obese patient. The pleural space can be identified by 
observing the normal motion of the lung during breathing. The liver and spleen, and 
occasionally the kidney, are used as guides to chest ultrasound searching for the pleural 
effusion. The air-filled lung surface totally reflects the ultrasound beam and produces a 
bright, echogenic line of sound reflection (Figure 1A). This characteristic pattern of bright 
echoes produced by a reverberation artifact is recognized as normal for the air-filled lung  
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and indicates the absence of a pleural effusion, but there is an observation that pointed out 
an appearance of 2-mm-thick pleural fluid layer in healthy individuals (Kocijančič et al., 
2005). The presence of a pleural effusion is diagnosed by the appearance of an anechoic 
space between the parietal pleura and the highly reflective visceral pleura-lung interface. 
The amount of pleural effusion visualized on an ultrasonogram can be assessed 
quantitatively (Remérand et al., 2010; Vignon et al., 2005) or semi-quantitatively (Kataoka, 
2007; Tsai et al., 2008). The following categories are one example of the semi-quantification 
of pleural effusion (Kataoka, 2007): small if the echo-free space is within the costophrenic 
angle, moderate if the echo-free space extends over the costophrenic angle and causes near 
separation of basal lung from the diaphragm, and large if the space is bigger and separates 
the basal lung from the diaphragm (Figures 1- B, C, D). 
    
Fig. 1. Examples of pleural effusion. (A) absent, (B) small, (C) moderate, (D) large collection 
of fluid. Asterisks indicate pleural effusion. Adapted from Kataoka (2007). (Adapted and 
reproduced with permission from Wiley Periodicals, Inc.) 
3.2 Accuracy of sonographic detection of pleural effusion 
Radiographic identification of pleural effusion is reported to be insensitive and detects only 
moderate to large accumulation of pleural fluid. Pleural effusion becomes visible on the 
upright lateral radiograph at a volume of approximately 50 ml as a meniscus in the posterior 
costophrenic sulcus. The meniscus becomes visible on the postero-anterior projection at a 
volume about 175 to 525 ml (Woodring, 1984) or 200 ml (Blackmore et al., 1996). To 
determine the accuracy of chest ultrasound for detecting pleural effusion in acutely 
decompensated heart failure patients, previous study evaluated the usefulness of chest 
ultrasound in comparison with physical signs, erect postero-anterior chest x-ray, and 
thoracic x-ray computed tomography (Kataoka & Takada, 2000). The incidence of pleural 
effusion detected by chest ultrasound was high when compared to plain chest radiograph 
(Table 1): postero-anterior projection of chest x-ray could not identify a very small amount 
(less than 100 ml) of pleural effusion, but chest ultrasound detected most of the pleural 
effusion. Many other studies have also confirmed the superiority of chest ultrasound for 
detection of small pleural effusion compared to simple chest radiographic technique 
(Gryminski et al., 1976; Kohan et al., 1986; Lipscomb et al., 1981; Yu et al., 1992; Zanobetti et 
al., 2011). Thus, the diagnosis of pleural effusions in critically ill patients has been 
revolutionized with the advent of chest ultrasound allowing easy bedside quantification of 
pleural fluid and making thoracentesis a safe procedure (Pneumatikos & Bouros, 2008). 
D C BA 
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Pleural Effusion by CT n X-ray Ultrasound n X-ray Ultrasound
Normal controls (n = 22)
   Absent 22 0 0 22 0 1 (5%)
Patient group (n = 60)
   Absent 10 0 1 (10%) 14 0 2 (14%)
   Present (ml)
      Very small (≤100) 15 2 (13%) 13 (87%) 15 0 12 (80%)
      Small (≤400) 20 9 (45%) 18 (90%) 23 6 (26%) 23 (100%)
      Moderate (≤700) 8 6 (75%) 8 (100%) 6 4 (67%) 6 (100%)
      Large 7 7 (100%) 7 (100%) 2 2 (100%) 2 (100%)
      Total 50 24 (48%) 46 (92%) 46 12 (26%) 43 (93%)
Right Hemithorax Left Hemithorax
 
Table 1. Comparison of the presence of signs of pleural effusion between plain chest x-ray 
and chest ultrasound in normal controls and patients with decompensated chronic heart 
failure. Adapted from Kataoka & Takada (2000). (Adapted and reproduced with permission 
from the American College of Cardiology) 
3.3 Clinical significance of ultrasound pleural effusion in heart failure patients 
In acutely worsening heart failure patients, the reported incidence of pleural effusion on 
chest ultrasound is high when compared to other heart failure-associated examinations 
(Kataoka & Takada, 2000). Namely, an observation of 60 acutely decompensated heart 
failure patients indicated that the incidence of pulmonary rales or wheezing was modest 
(56%) but that of other physical signs of jugular venous distension (38%) and peripheral 
edema (33%) was low. On erect postero-anterior plain chest radiograph, combined 
frequency of radiographic heart failure signs, consisting of the pulmonary edema (45%) 
and/or pleural effusion (41%), was low (61%), but the presence of ultrasound pleural 
effusion was high (90%). As such, diagnostic utility of chest ultrasound searching for pleural 
effusion in heart failure patients seems to be high in emergent situation. 
Recent studies have reported that ultrasound signs of pleural effusion were a common 
presenting heart failure-related sign for established heart failure patients during follow-up 
(Kataoka, 2007; Kataoka, 2011), and were strongly associated with the appearance of other 
heart failure-related symptoms and signs (Kataoka, 2010). The results also demonstrated 
that the ultrasound signs of pleural effusion had high diagnostic value for identifying heart 
failure status worsening, confirming that this sign was a useful marker in such patients 
during follow-up (Kataoka, 2010). Importantly, ultrasound-detected pleural effusion signs 
were often present in asymptomatic heart failure worsening with the minimal appearance of 
other heart failure-related signs, which was supported by recent observation (Kataoka, 
2011). Other than in the severity of leg edema, there were no differences in heart failure-
related signs between symptomatic (n = 45) and asymptomatic clinic visits (n = 38) with a 
positive ultrasound pleural effusion sign (Table 2). Unsuspected and not clinically apparent 
pleural effusion is easily detected by a simple chest ultrasound examination and may have 
an important bearing on therapeutic decisions and outcome. Detection of the ultrasound 
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pleural effusion can potentially become one of the leading signs of deterioration in heart 
failure during follow-up of established heart failure patients. Thus, chest ultrasound should 
appropriately be performed in established heart failure patients, with or without 
symptomatic change, in order to obtain objective evidence of worsening heart failure status. 
Symptomatic Events Asymptomatic Events
(n = 45)  (n = 38)
Amount of ultrasound pleural effusion
     Small degree 20 (44%) 24 (63%)
     Moderate degree 18 (40%) 14 (37%)
     Large degree 7 (16%) 0
Heart failure-related signs
     Leg edema
           Mild 12 (27%) 17 (45%)
           Moderate to severe 19 (42%) 0
           Total 31 (69%) 17 (45%) 0.044
     Audible third heart sound 11 (24%) 3 (8%) 0.075
     Pulmonary rales 12 (27%) 8 (21%) 0.613
     Fluid body weight gain 35 (78%) 23 (61%) 0.099
<0.0001
Variables P  Value
0.0257
 
Table 2. Comparison of heart failure-related signs between positive ultrasound pleural 
effusion events with (n = 45) and without (n = 38) symptomatic change. Values are 
presented as numbers (percentages) 
In established heart failure patients during follow-up, effects of the volume of pleural 
effusion on heart failure-associated symptoms, signs, and the requirement of hospitalization 
are still unknown. Based on my clinical records of heart-failure monitoring in 83 established 
heart failure patients, I evaluated the pleural fluid volume dependency of symptoms and 
signs, and/or the requirement of hospitalization. The results of this analysis have shown 
that heart failure-related symptoms were not different, and only several signs were different 
between worsening heart failure events in patients with moderate to large pleural fluid 
retention and those in patients with small pleural effusion (Table 3). However, worsening 
heart failure events with moderate to large pleural fluid retention required more 
hospitalization than those with small pleural effusion. Thus, determining the volume of 
pleural effusion is clinically important because the amount of pleural effusion can affect the 
clinical course of individual heart failure patients. 
3.4 Differentiation of heart failure-associated pleural effusion from other causes 
Pleural effusion can be caused by a variety of intrathoracic and systemic diseases (Golshan 
et al., 2002; Mattison et al., 1997) which may necessitate thoracentesis to determine the cause 
of the effusion as described below in this section. In established heart failure patients, 
pleural effusion usually appears in relation to worsening heart failure during follow-up. 
Treatment with additional diuretics could resolve the pleural effusion in such cases, 
confirming the cause of effusion with high probability due to worsening heart failure. 
Persistent or increased amounts of pleural effusion despite added diuretic therapy during 
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follow-up of established heart failure patients should first be considered a reflection of 
refractory heart failure and/or worsening of renal function, and requires concomitant 
consideration of other causes of pleural effusion. A review of my clinical records for heart-
failure monitoring of 83 established heart failure patients (follow-up period of 652 ± 456 
days) revealed unresolved pleural effusion due to refractory heart failure and/or renal 
failure in 12 study patients, but thoracentesis was required to reveal the cause in two other 
patients, one due to lung cancer and the other due to bacterial pneumonia (unpublished 
data). 
Chest ultrasound provides information regarding the nature of pleural effusion, e.g., 
transudates are echo-free, whereas echoic effusions are likely to be exudates (Yang et al., 
1992; Yu et al., 1992), but might be of limited value for identifying the cause of the pleural 
effusion. Thus, a persistent or increased amount of effusion on ultrasound despite the 
augmented treatment for decompensated heart failure status should be an indication for 
thoracentesis to evaluate the possible cause of effusions other than heart failure through 
analysis of the pleural fluid (Bartter et al., 1994; Light et al., 1972; Pneumatikos & Bouros, 
2008; Porcel et al., 2009; Porcel, 2011). In general, the traditional criteria of Light et al. (1972) 
(i.e., pleural fluid/serum total protein ratio > 0.5, pleural fluid/serum LDH ratio > 0.6, and 
pleural fluid LDH > 200 for identifying exudative pleural effusions) can be used to 
differentiate exudates from transudates with a negative predictive value of 96% and a 
sensitivity of 98%. A high incidence of misclassifications by Light’s criteria has been 
reported, however, in heart failure patients on diuretic therapy (Eid et al., 2002; Porcel et al., 
2009; Romero-Candeira et al., 2001; Roth et al., 1990). In such heart failure patients, 
differences in the amount of albumin in the serum and pleural fluid (discriminating level; 
around 1.2 g/dl) are useful for differentiating exudates from transudates (Eid et al., 2002; 
Romero-Candeira et al., 2001; Roth et al., 1990). 
Small Moderate to Large
(n = 44) (n = 39)
Heart failure-related symptoms 20 (45%) 25 (64%) 0.123
Heart failure-related signs
     Leg edema
           Mild 15 (34%) 27 (69%)
           Moderate to severe 9 (20%) 10 (26%)
           Total 24 (55%) 37 (95%) P<0.0001
     Audible third heart sound 4 (9%) 10 (26%) 0.045
     Pulmonary rales 10 (23%) 10 (26%) 0.757
     Fluid body weight gain 27 (61%) 31 (79%) 0.073
Required hospitarization 12 (27%) 20 (51%) 0.025
0.0001
Volume of Pleural Effusion by Ultrasound
Heart Failure-related Variable
P  Value
 
Table 3. Pleural effusion volume dependency of symptoms and signs of heart failure. Values 
are presented as numbers (percentages) 
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Recently, the pleural fluid level of natriuretic peptide, either B-type natriuretic peptide 
(BNP) or the amono-terminal fragment N-terminal pro-BNP (NT-pro-BNP), has been 
suggested as a useful adjunct for the diagnosis of heart failure-associated pleural effusion, 
including cardiac effusion misclassified as exudates by the criteria of Light (Kolditz et al., 
2006; Liao, et al., 2008; Long et al., 2010; Porcel et al., 2004, 2009; Tomcsányi et al., 2004). 
Some studies have shown a strong correlation of natriuretic peptide concentrations in serum 
and pleural fluid and equal diagnostic accuracies for serum and pleural fluid natriuretic 
peptide measurements for the discrimination of pleural effusions attributable to heart 
failure (Kolditz et al., 2006; Tomcsányi et al., 2004). Therefore, it could be claimed that it may 
not be necessary to perform diagnostic thoracentesis in patients with serum natriuretic 
concentrations exceeding a cut-off value with a high positive predictive value, making the 
diagnosis of heart failure as the underlying cause of the pleural effusion very likely in these 
patients. However, in all other patients with serum natriuretic concentrations below such a 
cut-off value, early diagnostic thoracentesis may be necessary to determine whether the 
effusion is exudates or transudates in nature (Mueller & Haltmayer, 2006). 
3.5 Advantages and limitations of thoracic sonography for evaluating heart failure 
This technique has several advantages for evaluating heart failure patients: 1) high 
diagnostic accuracy for diagnosing worsening heart failure through identifying ultrasound 
pleural effusion, e.g., bedside chest radiography is routinely performance under emergent 
conditions, but this technique offers limited diagnostic performance and efficacy for 
identifying pleural effusion (see sections “3.2” and “4”); 2) portability and performance ease 
at outpatient clinic or bedside with a hand-held device (Piccoli et al., 2005; Roelandt, 2003), 
e.g., though x-ray computed tomography has high diagnostic performance for identifying 
pleural effusion, this modality is not available or is not available quickly enough because it 
requires transportation of the patient to the radiology department; 3) short examination 
time, e.g., acquisition time to assess both hemithorax searching for pleural effusion is 
approximately 2 minutes (Tayal et at., 2006); 4) safety of the procedure due to the non-
ionizing nature of the examination; and 4) lower cost. Additionally, several studies have 
demonstrated that chest ultrasound can detect pulmonary edema (Agricola et al., 2005; 
Copetti et al., 2008; Jambrik et al., 2004; Lichtenstein et al., 1997, 2004; Zanobetti et al., 2011) 
and help to discriminate among the most important causes of acute dyspnea like pulmonary 
or cardiovascular diseases. The presence of diffuse “comet-tails” or B-line artifacts on chest 
ultrasound indicates diffuse alveolar-interstitial syndrome, which is often a sign of acute 
pulmonary edema. This condition rules out exacerbation of chronic obstructive pulmonary 
disease as the main cause of acute dyspnea (Lichtenstein & Mezière, 1998; Volpicelli et al., 
2008). These advantages make chest ultrasound a useful diagnostic tool with great potential 
for assisting decision-making and management of patients with heart failure. Several 
disadvantages include: 1) technical difficulty in obtaining a high quality of image in obese 
patients; 2) restricted field of view; and 3) somewhat operator-dependent findings. 
4. Reappraisal of chest x-ray for evaluation of heart failure patients 
Because chest radiography is still a standard method for evaluating fluid status in heart 
failure patients (Evans & Gleeson, 2004; Logue et al., 1963; McHugh et al., 1972; Meszaros, 
1973; Milne et al., 1985; Wiener et al., 1991), it is appropriate to briefly summarize the 
www.intechopen.com
Clinical Utility of Ultrasonographic Detection of  
Pleural Effusion for Evaluation of Heart Failure Patients 
 
149 
limitation of this modality for assessing heart failure status for comparison with the clinical 
role of chest ultrasound. Two important specific markers of fluid accumulation on plain 
chest radiograph are pleural effusion and interstitial edema (hilar haziness, peribronchial 
cuffing, Kerley’s B lines, or septal lines) or alveolar pulmonary edema. An erect postero-
anterior chest x-ray should be performed wherever possible, including a lateral decubitus 
film, when necessary, for detecting small pleural effusions (Moskowitz et al., 1973). Though 
chest x-ray signs of interstitial/alveolar pulmonary edema and pleural effusion are 
important markers of fluid retention, the diagnostic accuracy of these x-ray signs of 
pulmonary congestion in chronic heart failure is not very high (Chakko et al., 1991; Collins 
et al., 2006; Gadsbøll et al., 1989; Mahdyoon et al., 1989), presumably due to increased 
lymphatic drainage clearing of the flooded interstitium/alveoli (Szidon et al., 1972). Also, as 
described above (see section “3.2”), chest x-ray identification of pleural effusion is not 
sensitive and only detects moderate to large amounts of accumulation. Thus, clinicians 
cannot rule out body fluid retention in heart failure patients without radiographic signs of 
pulmonary congestion, particularly in those without chest x-ray signs of pleural effusion. 
Chest ultrasound allows accurate evaluation of fluid accumulation in the thorax, including 
pleural effusion, and pulmonary congestion due to worsening heart failure (Agricola et al., 
2005; Jambrik et al., 2004; Lichtenstein, et al., 1997, 2004; Zanobetti et al., 2011). 
5. Case presentation 
5.1 Patient no.1 
A 75-year-old female patient visited the hospital emergently with a complaint of New York 
Heart Association functional class III dyspnea and night cough. Physical examination 
disclosed an audible third heart sound and mild ankle edema. Electrocardiographic findings 
included sinus tachycardia of 105 beats/minute and non-specific ST-T changes. 
Echocardiography revealed dilated, generalized hypokinesis of the left ventricle with an 
ejection fraction of 23% and a diastolic volume of 200 ml. An erect postero-anterior chest  
x-ray film showed moderate cardiomegaly with mild hypervascularity in the upper lung 
field, but no apparent pleural effusion (Figure 2). Chest ultrasound revealed the collection of 
a large pleural effusion in both hemithoraces. Computed tomography confirmed the chest 
ultrasound findings. Worsening of heart failure status due to dilated cardiomyopathy was 
confirmed by the marked elevation of serum B-type natriuretic peptide level of 1865 pg/ml. 
The selected therapeutic option using extra-diuretics improved her clinical status; she lost 
2.6 kg body weight and chest ultrasound confirmed complete resolution of the pleural 
effusion. 
5.2 Patient no.2 
During follow-up of a 78-year-old male patient with a history of decompensated heart 
failure due to hypertension, he experienced New York Heart Association functional class III 
dyspnea at a regular clinic visit, and underwent a scheduled examination. Physical 
examination revealed mild leg edema and diffuse basal rales on auscultation. The 
electrocardiogram showed a regular sinus rhythm of 72 beats/minute and left ventricular 
hypertrophy. On echocardiogram, left ventricular size and function were normal based on a 
left ventricular diastolic volume of 68 ml, ejection fraction of 65%, and Doppler index of the 
ratio of mitral E wave to the A wave of 0.8. Plain erect postero-anterior chest x-ray was  
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Fig. 2. Chest x-ray film, x-ray computed tomogram, and chest ultrasound obtained from a 
75-year-old female with worsening heart failure due to idiopathic dilated cardiomyopathy. 
Lt = left; PLE = pleural effusion; Rt = right 
 
Fig. 3. Chest x-ray film, x-ray computed tomogram, and chest ultrasound obtained from a 
78-year-old male with worsening heart failure due to hypertensive heart disease. Lt = left; 
PLE = pleural effusion; Rt = right 
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normal except moderate cardiomegaly (Figure 3). There was no evidence of pleural effusion 
on postero-anterior chest x-ray. Chest ultrasound disclosed a moderate amount of pleural 
effusion in the right hemithorax and a small collection in the left. Computed tomography 
confirmed the chest ultrasound findings. Serum B-type natriuretic peptide was increased to 
381 pg/ml from 65 pg/ml measured at a recent clinic visit for clinical stability. Use of extra-
diuretics improved his clinical status with improvement of symptoms and lost of body 
weight of 3.1 kg, and the pleural effusion disappeared on chest ultrasound. 
6. Conclusion 
Heart failure is a leading cause of hospitalization, particularly in the elderly population, and 
the frequency of heart failure-related hospital re-admission in heart failure patients within 
the first 3 to 6 months is high (Vinson et al., 1990; Krumholz et al., 1997; Fonarow et al., 
2008). Heart failure-related hospitalizations are not benign events, with an increased (and 
independent) risk of mortality following the initial and each subsequent hospitalization for 
heart failure (Setoguchi et al., 2007; Solomon et al., 2007). Body fluid retention or congestion 
is the main characteristic feature for worsening heart failure, leading to hospitalization 
(Gheorghiade et al., 2006; Pang & Levy, 2010). Thus, early detection of excess body fluid 
accumulation is crucial for identifying worsening heart failure events in patients with heart 
failure. As described in this chapter, the use of chest ultrasound to determine pleural 
effusion allows for sensitive detection of worsening heart failure and will improve diagnosis 
and facilitate decision-making in heart failure patients. Widespread use of ultrasound, a 
method that is not technically difficult to perform or analyze, to evaluate pleural effusion in 
patients with heart failure is therefore warranted, irrespective of the accompanying 
symptoms, and will lead to a more accurate diagnosis. Of course, it should be kept in mind 
that, a lot of patients without pleural effusion on chest ultrasound have deterioration of 
heart failure status. Fortunately, physicians rarely use single observation in clinical decision-
making. Proper diagnosis of worsening heart failure requires clinicians to integrate elements 
of patient history, physical examination, and diagnostic test results together with 
knowledge of multiple pharmacologic and non-pharmacologic treatments. 
7. Future research 
Up to date, there is a paucity of data on the feasibility of using ultrasound pleural effusion 
as part of the diagnostic approach in patients with heart failure. Thus, additional study is 
necessary to answer the question of whether chest ultrasound pleural effusion may emerge 
as clinically useful in identifying worsening heart failure status. 
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